Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Ceska Gynekol ; 89(2): 114-119, 2024.
Article in English | MEDLINE | ID: mdl-38704223

ABSTRACT

Hidradenitis suppurativa is a chronic immune-mediated inflammatory disease that is manifested by formation of painful nodules, abscesses and suppurating fistulas, primarily in the intertriginous spaces. This painful, often under-diagnosed disease affects much more women. They are also exposed to certain specific challenges in the management of this disease, especially during menstruation or pregnancy. The treatment requires the interdisciplinary cooperation of a dermatologist, gynaecologist, obstetrician and last but not least an algesiologist and psychotherapist. Above all, early and correct diagnosis, initiation of therapy in the early stages of the disease, is a key, which also plays a fundamental role in controlling inflammatory activity, preventing complications and further prognosis.


Subject(s)
Gynecology , Hidradenitis Suppurativa , Hidradenitis Suppurativa/therapy , Humans , Female , Gynecology/methods , Patient Care Team , Pregnancy , Interprofessional Relations
2.
Folia Microbiol (Praha) ; 46(4): 359-60, 2001.
Article in English | MEDLINE | ID: mdl-11830950

ABSTRACT

One-hundred patients with candidosis of the skin, mucous membranes and nail plates (confirmed by cultivation) were examined. Topical or systemic antimycotic treatment was successful in 58 patients. After a complete evaluation, 42 patients were found to suffer from factors supporting candidosis--diabetes mellitus (12), anemia (3) and various local factors (10 patients); 27 patients showed a deficiency in cell-mediated immunity. In addition to intensive antimycotic therapy, successful treatment is affected by the actual immunity level and can be ensured by efficient immunomodulation treatment of immunodeficiency.


Subject(s)
Candida/pathogenicity , Candidiasis, Cutaneous/immunology , Immunocompromised Host , Antibodies, Fungal/blood , Antifungal Agents/therapeutic use , Antigen-Antibody Complex/blood , Candida/classification , Candidiasis, Cutaneous/drug therapy , Humans , Phagocytosis , Risk Factors , T-Lymphocytes/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...